Gel treatment for erectile dysfunction receives positive results from clinical trial

Futura Medical has announced positive results from a clinical trial looking into MED3000, a topical gel formulation for the treatment of erectile dysfunction (ED).

The results, from the confirmatory phase 3 clinical  study, FM71, were announced today (August 31).

MED3000 is a breakthrough, fast-acting gel produced by Futura Medical’s transdermal DermaSys drug delivery technology. It is CE marked in?Europe and CA marked in the?UK, signifying it has been assessed to meet high safety and environmental protection requirements?as a clinically proven topical treatment for adult men with ED helping them get an erection within 10 minutes.

Highly positive results

FM71 results are highly positive, in line with data generated in the previous study and broadly comparable with results from a recent ‘real world’, home use study.

Data that has already been accumulated shows MED3000 is an effective treatment option with a rapid onset of action and a favorable risk versus benefit profile ideally suited for over the counter (OTC) classification.

The company says it is expected to provide an alternative to existing ED treatments, that require a doctor’s prescription, for those patients seeking fewer systemic side-effects, and a spontaneous intercourse experience. It also provides an important treatment option for those patients who are currently precluded from using current prescription treatments such as those men taking nitrate medication.